1 | 0,5 mg Prevenar i.m. | - | - | - | - | [1] 51 51 |
2 | 0,5 mg seasonal influenza vaccine i.m. | - | - | - | - | [1] 51 51 |
3 | 0.9% sodium chloride | [2] Chloride ion Chloride ion, Sodium chloride | [1] D02056
D02056
| - | - | [4] 6 6, 14, 51, 53 |
4 | 1-(6-BENZOTHIAZOLYLSULFONYL)-5-CHLORO-1H-INDOLE-2-BUTANOIC ACID | [2] Butyric Acid Butyric Acid, Indole | [1] D05866
D05866
| - | - | [1] 51 51 |
5 | 1-22460 | - | - | - | - | [1] 51 51 |
6 | 10% Nitroglycerine in Propylene Glycol, USP | [2] Nitroglycerin Nitroglycerin, Propylene glycol | [2] D00078
D00078
,
D00515
| - | - | [1] 51 51 |
7 | 2 ml of whole blood sample will be collected on EDTA tube | [1] Edetic acid Edetic acid | [8] D00052
D00052
,
D00571
,
D01802
,
D03943
,
D03944
,
D03945
,
D03946
,
D03947
| - | - | [1] 51 51 |
8 | 2-(((2E)-3-(3-methoxy-4-(2-propyn-1-yloxy)phenyl)-1-oxo-2-propen-1-yl)amino)benzoic acid | [1] Benzoic acid Benzoic acid | [1] D00038
D00038
| - | - | [1] 51 51 |
9 | 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-[(N-butyloxylcarbamate)-sulphonamide] sodium salt | - | - | - | - | [2] 51 51, 85 |
10 | A novel synthetic, orally-administered, non-peptide small molecule, which acts as an agonist of the melanocortin-1 receptor (MC1R) | - | - | - | - | [1] 51 51 |
11 | Abatacept | [1] Abatacept Abatacept | [1] D03203
D03203
| [2] CD80 CD80, CD86 💬 | [12] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | [26] 11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 |
12 | Abituzumab | [1] Abituzumab Abituzumab | - | - | - | [1] 51 51 |
13 | Abituzumab 1500 mg | [1] Abituzumab Abituzumab | - | - | - | [1] 51 51 |
14 | Abituzumab 500 mg | [1] Abituzumab Abituzumab | - | - | - | [1] 51 51 |
15 | ABR-215757 | - | - | - | - | [2] 49 49, 51 |
16 | ACE-1334 | - | - | - | - | [1] 51 51 |
17 | Acetaminophen | [1] Acetaminophen Acetaminophen | [1] D00217
D00217
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [16] 11 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271, 300, 337 |
18 | Acetate | [1] Acetate Acetate | - | - | - | [43] 1 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 |
19 | Acetylcysteine | [1] Acetylcysteine Acetylcysteine | [1] D00221
D00221
| - | - | [20] 6 6, 13, 19, 20, 34, 49, 51, 53, 58, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337 |
20 | ACETYLSALICYLIC ACID | [1] Acetylsalicylic acid Acetylsalicylic acid | [1] D00109
D00109
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [4] 13 13, 46, 51, 210 |
21 | ACHIM as solute (10^9 intestinal microbes/ml) | - | - | - | - | [1] 51 51 |
22 | Acotiamide | [1] Acotiamide Acotiamide | - | - | - | [1] 51 51 |
23 | ACT-064992 | - | - | - | - | [5] 51 51, 85, 86, 88, 210 |
24 | ACT-293987 | - | - | - | - | [3] 51 51, 86, 88 |
25 | Ad26.COV2.S | - | - | - | - | [5] 13 13, 35, 46, 49, 51 |
26 | Adempas | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [5] 51 51, 86, 88, 225, 299 |
27 | ADEMPAS - 1 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 |
28 | ADEMPAS - 1,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 |
29 | ADEMPAS - 2 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 |
30 | ADEMPAS - 2,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 |
31 | Adipose tissue harvest | - | - | - | - | [1] 51 51 |
32 | Administration of rituximab and methylprednisolone | [2] Methylprednisolone Methylprednisolone, Rituximab | [7] D00407
D00407
,
D00751
,
D00979
,
D02994
,
D05000
,
D05001
,
D05002
| [2] MS4A1 MS4A1, NR3C1 💬 | [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 51 51 |
33 | ADSVF application in the right hand | - | - | - | - | [1] 51 51 |
34 | AIMSPRO | - | - | - | - | [2] 13 13, 51 |
35 | Air | - | - | - | - | [8] 3 3, 13, 51, 58, 85, 97, 193, 299 |
36 | Air filled balloon catheter | - | - | - | - | [1] 51 51 |
37 | Ajulemic acid | [1] Ajulemic acid Ajulemic acid | [1] D11312
D11312
| [1] CNR2 CNR2 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 50 50, 51, 299 |
38 | AL | - | - | - | - | [10] 5 5, 7, 13, 28, 51, 67, 86, 97, 114, 127 |
39 | Albumin | - | - | - | - | [3] 2 2, 20, 51 |
40 | ALEMTUZUMAB | [1] Alemtuzumab Alemtuzumab | [1] D02802
D02802
| [1] CD52 CD52 💬 | - | [17] 13 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 |
41 | Alginic acid | [1] Alginic acid Alginic acid | [1] D02324
D02324
| - | - | [1] 51 51 |
42 | Allogeneic hematopoietic stem cell transplantation | - | - | - | - | [8] 28 28, 51, 60, 62, 65, 164, 284, 285 |
43 | Allogeneic Mesenchymal Stem Cells (AlloMSC) | - | - | - | - | [2] 51 51, 53 |
44 | AlloRx | - | - | - | - | [8] 2 2, 6, 13, 46, 51, 85, 90, 226 |
45 | Alpha-2C AR antagonist | - | - | - | - | [1] 51 51 |
46 | Alprostadil | [1] Alprostadil Alprostadil | [2] D00180
D00180
,
D02705
| [1] PTGER1 PTGER1 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer 💬 | [2] 51 51, 70 |
47 | AM-01 | - | - | - | - | [1] 51 51 |
48 | Ambrisentan | [1] Ambrisentan Ambrisentan | [1] D07077
D07077
| [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [7] 51 51, 84, 85, 86, 88, 210, 211 |
49 | Amlodipine | [1] Amlodipine Amlodipine | [3] D00615
D00615
,
D02914
,
D07450
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 51 51, 67, 298 |
50 | Amlodipine Gel | [1] Amlodipine Amlodipine | [3] D00615
D00615
,
D02914
,
D07450
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
51 | Anaerobically Cultivated Human Intestinal Microbiota | - | - | - | - | [1] 51 51 |
52 | Anaerobically Cultivated medium | - | - | - | - | [1] 51 51 |
53 | Anti-CT51 antigen mAb | - | - | - | - | [1] 51 51 |
54 | ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN FROM RABBITS | - | - | - | - | [1] 51 51 |
55 | Anti-integrin alphaV mAb | - | - | - | - | [1] 51 51 |
56 | Anti-pandemic H1N1 influenza vaccine | - | - | - | - | [6] 46 46, 49, 50, 51, 53, 107 |
57 | Anti-Thymocyte Globulin | - | - | - | - | [18] 11 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 |
58 | Anti-Thymocyte Globulin, Rabbit | [2] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Rabbit | - | - | - | [1] 51 51 |
59 | ASASANTIN Retard | - | - | - | - | [1] 51 51 |
60 | Asasantin Retard ® | - | - | - | - | [1] 51 51 |
61 | ASC | - | - | - | - | [4] 36 36, 51, 96, 97 |
62 | Aspirin | [1] Acetylsalicylic acid Acetylsalicylic acid | [1] D00109
D00109
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [12] 13 13, 22, 34, 46, 49, 51, 58, 86, 113, 158, 210, 231 |
63 | Assigned Interventions CD19/BCMA CAR T-cells | - | - | - | - | [3] 49 49, 51, 53 |
64 | Atorvastatin | [1] Atorvastatin Atorvastatin | [3] D00258
D00258
,
D00887
,
D07474
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [18] 13 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 299 |
65 | AUC of MPA measure | - | - | - | - | [1] 51 51 |
66 | Autologous ASC | - | - | - | - | [1] 51 51 |
67 | Autologous Hematopoietic Stem Cell Transplantation | - | - | - | - | [7] 11 11, 13, 14, 28, 49, 51, 84 |
68 | Autologous Regulatory ?-cells | - | - | - | - | [1] 51 51 |
69 | Autologous Stem Cells | - | - | - | - | [2] 13 13, 51 |
70 | Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells | - | - | - | - | [1] 51 51 |
71 | AVID200 | - | - | - | - | [1] 51 51 |
72 | Aviptadil | [1] Aviptadil Aviptadil | [1] D12127
D12127
| - | - | [5] 49 49, 51, 84, 85, 86 |
73 | BAL | - | - | - | - | [5] 49 49, 51, 84, 85, 299 |
74 | Baricitinib | [1] Baricitinib Baricitinib | [1] D10308
D10308
| [2] JAK1 JAK1, JAK2 💬 | [35] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [13] 41 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 268, 269, 325 |
75 | BAY63-2521 | - | - | - | - | [3] 51 51, 86, 299 |
76 | Beam | [1] Tricyclazole Tricyclazole | - | - | - | [2] 6 6, 51 |
77 | BELIMUMAB | [1] Belimumab Belimumab | [1] D03068
D03068
| [1] TNFSF13B TNFSF13B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [12] 11 11, 13, 43, 44, 46, 49, 51, 53, 66, 222, 296, 300 |
78 | Belumosudil | [1] Belumosudil Belumosudil | [1] D11815
D11815
| [1] ROCK2 ROCK2 💬 | [21] Axon guidance Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
79 | Belumosudil (KD025) | [1] Belumosudil Belumosudil | [1] D11815
D11815
| [1] ROCK2 ROCK2 💬 | [21] Axon guidance Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
80 | Benzoic acid | [1] Benzoic acid Benzoic acid | [1] D00038
D00038
| - | - | [1] 51 51 |
81 | BERMEKIMAB | [1] Bermekimab Bermekimab | [1] D11253
D11253
| [1] IL1A IL1A 💬 | [21] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Alzheimer disease, Cellular senescence, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Inflammatory bowel disease, Influenza A, Leishmaniasis, MAPK signaling pathway, Measles, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 51 51 |
82 | BH4 | - | - | - | - | [5] 51 51, 86, 124, 240, 299 |
83 | BIBF 1120 | - | - | - | - | [2] 51 51, 85 |
84 | Biopsy | - | - | - | - | [4] 19 19, 51, 78, 193 |
85 | Blood coagulation factor XIII | [1] Factor XIII (human) Factor XIII (human) | - | - | - | [1] 51 51 |
86 | Blood sample | - | - | - | - | [18] 8 8, 13, 46, 49, 51, 53, 61, 65, 66, 84, 96, 97, 107, 127, 235, 274, 288, 299 |
87 | Blood samples | - | - | - | - | [9] 13 13, 41, 46, 51, 61, 97, 227, 240, 271 |
88 | Blood sampling | - | - | - | - | [6] 13 13, 17, 19, 46, 51, 96 |
89 | Blood test | - | - | - | - | [6] 36 36, 51, 86, 113, 162, 299 |
90 | BMS-986020 | [1] BMS-986020 BMS-986020 | - | - | - | [2] 51 51, 85 |
91 | BNT162b2 | - | - | - | - | [5] 13 13, 35, 46, 49, 51 |
92 | Bone marrow transplantation | - | - | - | - | [4] 51 51, 60, 284, 285 |
93 | BORTEZOMIB | [1] Bortezomib Bortezomib | [1] D03150
D03150
| [1] PSMB5 PSMB5 💬 | [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [16] 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 228, 256, 283, 288, 331 |
94 | Bosentan | [1] Bosentan Bosentan | [2] D01227
D01227
,
D07538
| [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [11] 13 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 |
95 | Bosentan (Tracleer) | [1] Bosentan Bosentan | [2] D01227
D01227
,
D07538
| [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
96 | Bosentan 125 mg | [1] Bosentan Bosentan | [2] D01227
D01227
,
D07538
| [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
97 | Bosentan 62.5 mg | [1] Bosentan Bosentan | [2] D01227
D01227
,
D07538
| [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
98 | Bosentan group | [1] Bosentan Bosentan | [2] D01227
D01227
,
D07538
| [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
99 | BOSENTAN MONOHYDRATE | [1] Bosentan Bosentan | [2] D01227
D01227
,
D07538
| [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [4] 51 51, 84, 86, 88 |
100 | Botox | [1] Botulinum toxin type A Botulinum toxin type A | [1] D00783
D00783
| [1] SNAP25 SNAP25 💬 | [2] Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | [6] 2 2, 6, 13, 51, 149, 226 |
101 | BOTOX® solution | [1] Botulinum toxin type A Botulinum toxin type A | [1] D00783
D00783
| [1] SNAP25 SNAP25 💬 | [2] Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | [1] 51 51 |
102 | Botulinum toxin A | [1] Botulinum toxin type A Botulinum toxin type A | [1] D00783
D00783
| [1] SNAP25 SNAP25 💬 | [2] Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | [4] 13 13, 51, 149, 226 |
103 | Botulinum toxin type B | [1] Botulinum toxin type B Botulinum toxin type B | [1] D02735
D02735
| [1] SNAP25 SNAP25 💬 | [2] Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | [3] 2 2, 6, 51 |
104 | Botulinum toxin type B (2500 units / vial) | [1] Botulinum toxin type B Botulinum toxin type B | [1] D02735
D02735
| [1] SNAP25 SNAP25 💬 | [2] Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | [1] 51 51 |
105 | Botulinum toxin(Botox) | [1] Botulinum toxin type A Botulinum toxin type A | [1] D00783
D00783
| [1] SNAP25 SNAP25 💬 | [2] Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | [1] 51 51 |
106 | Bovine type I collagen | [1] Bovine type I collagen Bovine type I collagen | - | - | - | [1] 51 51 |
107 | Brentuximab | [1] Brentuximab vedotin Brentuximab vedotin | [1] D09587
D09587
| [10] TNFRSF8 TNFRSF8, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [11] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [2] 49 49, 51 |
108 | Brentuximab vedotin | [1] Brentuximab vedotin Brentuximab vedotin | [1] D09587
D09587
| [10] TNFRSF8 TNFRSF8, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [11] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [2] 49 49, 51 |
109 | Brodalumab | [1] Brodalumab Brodalumab | [1] D10061
D10061
| [1] IL17RA IL17RA 💬 | [3] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway 💬 | [2] 37 37, 51 |
110 | Bronchoalveolar lavage (BAL fluid) | - | - | - | - | [3] 49 49, 51, 85 |
111 | Bupivacaine | [1] Bupivacaine Bupivacaine | [2] D01450
D01450
,
D07552
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [8] 46 46, 51, 53, 70, 96, 168, 226, 298 |
112 | Buspirone | [1] Buspirone Buspirone | [2] D00702
D00702
,
D07593
| [2] DRD2 DRD2, HTR1A 💬 | [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | [3] 6 6, 51, 179 |
113 | Busulfan | [1] Busulfan Busulfan | [1] D00248
D00248
| - | - | [13] 19 19, 20, 28, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 |
114 | Butanoic acid | [1] Butyric Acid Butyric Acid | [1] D05866
D05866
| - | - | [3] 34 34, 51, 97 |
115 | C-82 Topical Gel, 1% | - | - | - | - | [1] 51 51 |
116 | C21 | - | - | - | - | [2] 51 51, 85 |
117 | C225 | - | - | - | - | [2] 51 51, 86 |
118 | Calcipotriene | [1] Calcipotriol Calcipotriol | [1] D01125
D01125
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 51 51 |
119 | Calcium | [1] Calcium Calcium | - | - | - | [30] 3 3, 6, 13, 15, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 256, 265, 274, 298, 299 |
120 | Calcium Channel Blockers | [1] Calcium Calcium | - | - | - | [1] 51 51 |
121 | CAM2043 | - | - | - | - | [1] 51 51 |
122 | Campath | [1] Alemtuzumab Alemtuzumab | [1] D02802
D02802
| [1] CD52 CD52 💬 | - | [12] 19 19, 20, 49, 51, 60, 62, 65, 164, 234, 283, 285, 326 |
123 | CAPILLAREMA | - | - | - | - | [1] 51 51 |
124 | Carbon | [1] Activated charcoal Activated charcoal | - | - | - | [9] 6 6, 46, 50, 51, 85, 86, 96, 97, 298 |
125 | Carbon dioxide | [2] Activated charcoal Activated charcoal, Carbon dioxide | [1] D00004
D00004
| - | - | [3] 50 50, 51, 97 |
126 | CC | - | - | - | - | [14] 13 13, 28, 46, 49, 51, 56, 84, 85, 96, 97, 98, 162, 202, 271 |
127 | CC-4047 | - | - | - | - | [2] 28 28, 51 |
128 | CD | - | - | - | - | [7] 6 6, 13, 46, 51, 96, 97, 265 |
129 | CD34 selected autologous hematopoietic cells | - | - | - | - | [1] 51 51 |
130 | CD34+SC | - | - | - | - | [1] 51 51 |
131 | Cetuximab | [1] Cetuximab Cetuximab | [1] D03455
D03455
| [1] EGFR EGFR 💬 | [48] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis 💬 | [5] 34 34, 51, 86, 89, 331 |
132 | ChAdOx1 nCoV-19 | [1] AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | [3] 46 46, 51, 299 |
133 | Chloride | [1] Chloride ion Chloride ion | - | - | - | [29] 6 6, 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 67, 78, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 271, 288, 296, 297, 299, 338 |
134 | Cialis | [1] Tadalafil Tadalafil | [1] D02008
D02008
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 |
135 | CILOSTAZOL | [1] Cilostazol Cilostazol | [1] D01896
D01896
| [3] PDE3A PDE3A, PDE3B, TBXA2R 💬 | [14] Apelin signaling pathway Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 51 51, 70, 124 |
136 | Clobetasol | [1] Clobetasol Clobetasol | [1] D07715
D07715
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [4] 39 39, 46, 51, 162 |
137 | Comirnaty | [1] Pfizer-BioNTech COVID-19 Vaccine Pfizer-BioNTech COVID-19 Vaccine | [1] D11971
D11971
| - | - | [5] 13 13, 46, 51, 53, 299 |
138 | Companion diagnostic ( CDx) | - | - | - | - | [1] 51 51 |
139 | COVID-19 mRNA Vaccine (nucleoside modified) | - | - | - | - | [3] 13 13, 46, 51 |
140 | COVID-19 mRNA vaccine (nucleoside-modified) | - | - | - | - | [4] 13 13, 46, 51, 299 |
141 | COVID-19 mRNA vaccine Moderna (CX-024414) | - | - | - | - | [4] 13 13, 46, 51, 299 |
142 | COVID-19 vaccine | - | - | - | - | [3] 46 46, 49, 51 |
143 | COVID-19 Vaccine (ChAdOx1-S [recombinant]) | - | - | - | - | [3] 46 46, 51, 299 |
144 | COVID-19 Vaccine AstraZeneca | [1] AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | [3] 46 46, 51, 53 |
145 | COVID-19 vaccine AstraZeneca (ChAdOx1 nCoV-19) | [1] AstraZeneca COVID-19 Vaccine AstraZeneca COVID-19 Vaccine | - | - | - | [3] 46 46, 51, 299 |
146 | COVID-19 Vaccine Moderna | [1] Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | [1] D12114
D12114
| - | - | [4] 46 46, 51, 65, 299 |
147 | Cuprimine (penicillamine) | [1] Penicillamine Penicillamine | [1] D00496
D00496
| - | - | [1] 51 51 |
148 | Currently available therapy in the community | - | - | - | - | [1] 51 51 |
149 | Cutaneous iontophoresis of treprostinil | [1] Treprostinil Treprostinil | [1] D06213
D06213
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 51 51 |
150 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] D00287
D00287
,
D07760
| - | - | [45] 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 |
151 | Cyclophosphamide Injection 1g | [1] Cyclophosphamide Cyclophosphamide | [2] D00287
D00287
,
D07760
| - | - | [3] 50 50, 51, 52 |
152 | Dabigatran | [1] Dabigatran Dabigatran | [1] D09707
D09707
| [1] F2 F2 💬 | [8] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬 | [4] 51 51, 85, 91, 124 |
153 | Dabigatran etexilate | [2] Dabigatran Dabigatran, Dabigatran etexilate | [2] D07144
D07144
,
D09707
| [1] F2 F2 💬 | [8] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬 | [1] 51 51 |
154 | Dasatinib | [1] Dasatinib Dasatinib | [2] D03658
D03658
,
D06414
| [8] ABL1 ABL1, EPHA2, FYN, KIT, LCK, PDGFRB, SRC, YES1 💬 | [77] Acute myeloid leukemia Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | [2] 51 51, 85 |
155 | Depletion of CD3/CD19 in an autologous stem cell transplant | - | - | - | - | [2] 49 49, 51 |
156 | Depot leuprolide acetate 3.75 mg | [2] Acetate Acetate, Leuprolide | [1] D00989
D00989
| [1] GNRHR GNRHR 💬 | [2] GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | [1] 51 51 |
157 | Dersimelagon | - | - | - | - | [2] 51 51, 254 |
158 | DI-17E6 | - | - | - | - | [1] 51 51 |
159 | Diagnostic Test: CMRI | - | - | - | - | [2] 51 51, 86 |
160 | Diagnostic Test: Imaging | - | - | - | - | [1] 51 51 |
161 | Diagnostic Test: P-MPA concentration | - | - | - | - | [1] 51 51 |
162 | Diagnostic Test: Pulmonary function test | - | - | - | - | [1] 51 51 |
163 | Diagnostic Test: Vasculopathy assessment | - | - | - | - | [1] 51 51 |
164 | DIGNA P144 CREAM | - | - | - | - | [1] 51 51 |
165 | Diltiazem | [1] Diltiazem Diltiazem | [3] D00616
D00616
,
D03830
,
D07845
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 51 51, 58, 86 |
166 | Diltiazem Gel 2% | [1] Diltiazem Diltiazem | [3] D00616
D00616
,
D03830
,
D07845
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
167 | DIMETHYL FUMARATE | [1] Dimethyl fumarate Dimethyl fumarate | [1] D03846
D03846
| [1] KEAP1 KEAP1 💬 | [6] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | [4] 13 13, 51, 86, 296 |
168 | Dimethyl Fumarate (DMF) | [1] Dimethyl fumarate Dimethyl fumarate | [1] D03846
D03846
| [1] KEAP1 KEAP1 💬 | [6] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | [3] 13 13, 51, 86 |
169 | Diphenhydramine | [1] Diphenhydramine Diphenhydramine | [6] D00300
D00300
,
D00669
,
D02419
,
D03285
,
D03360
,
D03854
| [1] HRH1 HRH1 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [10] 11 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 |
170 | Dipyridamole | [1] Dipyridamole Dipyridamole | [1] D00302
D00302
| [2] PDE4A PDE4A, PDE5A 💬 | [6] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [6] 46 46, 49, 51, 66, 96, 224 |
171 | Divalproex sodium | - | - | - | - | [1] 51 51 |
172 | Domperidone | [1] Domperidone Domperidone | [2] D01745
D01745
,
D07868
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [5] 6 6, 13, 17, 51, 230 |
173 | Double-Blind Rituximab | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 51 51 |
174 | Drug treatment | - | - | - | - | [4] 46 46, 51, 74, 271 |
175 | Dupilumab | [1] Dupilumab Dupilumab | [1] D10354
D10354
| [1] IL4R IL4R 💬 | [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [4] 51 51, 98, 160, 162 |
176 | Dupilumab 300Mg Solution for Injection | [1] Dupilumab Dupilumab | [1] D10354
D10354
| [1] IL4R IL4R 💬 | [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 51 51 |
177 | EDTA | [1] Edetic acid Edetic acid | [8] D00052
D00052
,
D00571
,
D01802
,
D03943
,
D03944
,
D03945
,
D03946
,
D03947
| - | - | [2] 51 51, 60 |
178 | EMA/CHMP/212874/2015 | - | - | - | - | [1] 51 51 |
179 | EMD 525797 | - | - | - | - | [1] 51 51 |
180 | ENDOPROST | - | - | - | - | [1] 51 51 |
181 | ENDOPROST - 0.05 MG/0.5 ML CONCENTRATO PER SOLUZIONE PER INFUSIONE 1 FIALA | - | - | - | - | [1] 51 51 |
182 | ENDOPROST 0,05MG/0,5ML 1F | - | - | - | - | [1] 51 51 |
183 | ENDOPROST 50*INFUS 1F 0,050MG/ | - | - | - | - | [1] 51 51 |
184 | Endothelin receptor blocker | - | - | - | - | [1] 51 51 |
185 | Erbitux | [1] Cetuximab Cetuximab | [1] D03455
D03455
| [1] EGFR EGFR 💬 | [48] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis 💬 | [2] 51 51, 86 |
186 | Esbriet | [1] Pirfenidone Pirfenidone | [1] D01583
D01583
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 | [84] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [4] 46 46, 51, 85, 228 |
187 | Ethanol | [1] Ethanol Ethanol | [4] D00068
D00068
,
D02798
,
D04855
,
D06542
| - | - | [4] 51 51, 97, 279, 280 |
188 | EX VIVO CULTURED HUMAN MESENCHYMAL STEM CELLS | - | - | - | - | [2] 51 51, 107 |
189 | Factor XIII | [1] Factor XIII (human) Factor XIII (human) | - | - | - | [3] 51 51, 97, 288 |
190 | Fasudil | [1] Fasudil Fasudil | [1] D07941
D07941
| [2] ROCK1 ROCK1, ROCK2 💬 | [23] Axon guidance Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [4] 2 2, 5, 7, 51 |
191 | FCR001 | - | - | - | - | [1] 51 51 |
192 | Fibrogammin® 1250 | - | - | - | - | [1] 51 51 |
193 | Fibrogammin®P, coagulation factor XIII concentrate (Human) | [1] Factor XIII (human) Factor XIII (human) | - | - | - | [1] 51 51 |
194 | Filgrastim | [1] Filgrastim Filgrastim | [1] D03235
D03235
| [1] CSF3R CSF3R 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [28] 2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 |
195 | Fludarabine | [1] Fludarabine Fludarabine | [2] D01907
D01907
,
D07966
| [1] RRM1 RRM1 💬 | [5] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | [18] 13 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 286, 326 |
196 | Fludarabine phosphate | [2] Fludarabine Fludarabine, Phosphate ion | [2] D01907
D01907
,
D07966
| [1] RRM1 RRM1 💬 | [5] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | [12] 28 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286 |
197 | Fractional carbon dioxide laser | [2] Activated charcoal Activated charcoal, Carbon dioxide | [1] D00004
D00004
| - | - | [1] 51 51 |
198 | Fresolimumab | [1] Fresolimumab Fresolimumab | [1] D09620
D09620
| [3] TGFB1 TGFB1, TGFB2, TGFB3 💬 | [35] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Amoebiasis, Cell cycle, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Dilated cardiomyopathy, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Intestinal immune network for IgA production, Leishmaniasis, MAPK signaling pathway, Malaria, MicroRNAs in cancer, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬 | [3] 51 51, 222, 274 |
199 | From August 2020 'no additional treatment' | - | - | - | - | [1] 51 51 |
200 | FT011 | - | - | - | - | [1] 51 51 |
201 | FT011 100 mg | - | - | - | - | [1] 51 51 |
202 | FT011 200 mg | - | - | - | - | [1] 51 51 |
203 | G-CSF | [1] Filgrastim Filgrastim | [1] D03235
D03235
| [1] CSF3R CSF3R 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [16] 2 2, 6, 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 |
204 | G451990 | - | - | - | - | [2] 51 51, 85 |
205 | Genetic: FCX-013 | - | - | - | - | [1] 51 51 |
206 | GLIVEC | [1] Imatinib Imatinib | [2] D01441
D01441
,
D08066
| [3] ABL1 ABL1, KIT, PDGFRA 💬 | [32] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [2] 51 51, 86 |
207 | Glivec 100 mg Filmtabletten | [1] Imatinib Imatinib | [2] D01441
D01441
,
D08066
| [3] ABL1 ABL1, KIT, PDGFRA 💬 | [32] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [2] 51 51, 86 |
208 | GLPG1690 | - | - | - | - | [2] 51 51, 85 |
209 | Glycyrrhizin | [1] Glycyrrhizic acid Glycyrrhizic acid | [1] D00157
D00157
| - | - | [1] 51 51 |
210 | GM-CSF | - | - | - | - | [3] 51 51, 60, 229 |
211 | Gran | - | - | - | - | [1] 51 51 |
212 | GS-248 | - | - | - | - | [1] 51 51 |
213 | GSK2330811 | - | - | - | - | [2] 51 51, 96 |
214 | GSK2330811 Solution for Injection, 100mg/ml | - | - | - | - | [1] 51 51 |
215 | GUSELKUMAB | [1] Guselkumab Guselkumab | [1] D10438
D10438
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [5] 37 37, 41, 51, 96, 97 |
216 | Guselkumab Dose 1 | [1] Guselkumab Guselkumab | [1] D10438
D10438
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [3] 51 51, 96, 97 |
217 | Guselkumab Dose 2 | [1] Guselkumab Guselkumab | [1] D10438
D10438
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [3] 51 51, 96, 97 |
218 | Hematopoietic Stem Cell Transplantation | - | - | - | - | [13] 11 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285 |
219 | HIDONAC*EV 1FL 5G 25ML | - | - | - | - | [1] 51 51 |
220 | High-dose intravenous immunoglobulin (Venoglobulin-IH) | - | - | - | - | [1] 51 51 |
221 | Hizentra | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [4] 14 14, 50, 51, 65 |
222 | Human Anti-Transforming Growth Factor Beta-1 Monoclonal Antibody | - | - | - | - | [1] 51 51 |
223 | Human normal immunoglobulin | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [9] 11 11, 13, 14, 43, 45, 50, 51, 63, 65 |
224 | Human normal immunoglobulin for intravenous (IV) administration | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 51 51 |
225 | Human normal immunoglobulin for intravenous administration | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [3] 14 14, 51, 65 |
226 | Human normal immunoglobulin for subcutaneous administration | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [2] 51 51, 65 |
227 | Hyaluronidase | [1] Hyaluronidase Hyaluronidase | [3] D04455
D04455
,
D04456
,
D06604
| - | - | [5] 14 14, 28, 51, 65, 331 |
228 | Hyaluronidase injected intradermally | [1] Hyaluronidase Hyaluronidase | [3] D04455
D04455
,
D04456
,
D06604
| - | - | [1] 51 51 |
229 | Hyperimmune caprine serum | - | - | - | - | [1] 51 51 |
230 | Hyperoxia | - | - | - | - | [2] 51 51, 85 |
231 | HZN-825 | - | - | - | - | [2] 51 51, 85 |
232 | HZN-825 BID | - | - | - | - | [1] 51 51 |
233 | HZN-825 QD | - | - | - | - | [1] 51 51 |
234 | Idrossiclorochina solfato | - | - | - | - | [1] 51 51 |
235 | Ifetroban | [1] Ifetroban Ifetroban | [1] D04500
D04500
| [1] TBXA2R TBXA2R 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 💬 | [3] 51 51, 86, 113 |
236 | IgPro10 | - | - | - | - | [3] 14 14, 51, 65 |
237 | IgPro20 | - | - | - | - | [4] 14 14, 50, 51, 65 |
238 | Iguratimod | [1] Iguratimod Iguratimod | [1] D01146
D01146
| [1] NFKB1 NFKB1 💬 | [76] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease - COVID-19, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Longevity regulating pathway, MAPK signaling pathway, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway 💬 | [4] 46 46, 51, 53, 271 |
239 | Ilomedin | - | - | - | - | [1] 51 51 |
240 | Iloprost | [1] Iloprost Iloprost | [1] D02721
D02721
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [4] 51 51, 84, 85, 86 |
241 | Iloprost Injection, for intravenous use | [1] Iloprost Iloprost | [1] D02721
D02721
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 51 51 |
242 | Iloprost low dose | [1] Iloprost Iloprost | [1] D02721
D02721
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 51 51 |
243 | ILOPROST SALE DI TROMETAMOLO | [1] Iloprost Iloprost | [1] D02721
D02721
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 51 51 |
244 | Iloprost therapy up to 2 ng/kg x min | [1] Iloprost Iloprost | [1] D02721
D02721
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 51 51 |
245 | ILOPROST TROMETAMOL | [2] Iloprost Iloprost, Tromethamine | [2] D00396
D00396
,
D02721
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 51 51 |
246 | Imatinib | [1] Imatinib Imatinib | [2] D01441
D01441
,
D08066
| [3] ABL1 ABL1, KIT, PDGFRA 💬 | [32] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [12] 13 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 |
247 | IMATINIB MESILATO | [1] Imatinib Imatinib | [2] D01441
D01441
,
D08066
| [3] ABL1 ABL1, KIT, PDGFRA 💬 | [32] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 51 51 |
248 | Imatinib Mesylate | [1] Imatinib Imatinib | [2] D01441
D01441
,
D08066
| [3] ABL1 ABL1, KIT, PDGFRA 💬 | [32] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [5] 13 13, 28, 34, 51, 86 |
249 | Imiquimod | [1] Imiquimod Imiquimod | [1] D02500
D02500
| [1] TLR7 TLR7 💬 | [5] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Influenza A, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway 💬 | [2] 34 34, 51 |
250 | Imiquimod 5% Cream | [1] Imiquimod Imiquimod | [1] D02500
D02500
| [1] TLR7 TLR7 💬 | [5] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Influenza A, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway 💬 | [2] 34 34, 51 |
251 | Immunoglobulina normale umana | - | - | - | - | [1] 51 51 |
252 | Immunoglobulina Normale Umana per somministrazione endovenosa | - | - | - | - | [1] 51 51 |
253 | Immunoglobulina Normale Umana per somministrazione sottocutanea | - | - | - | - | [1] 51 51 |
254 | IMMUNOGLOBULINA UMANA NORMALE | - | - | - | - | [2] 51 51, 65 |
255 | Imnovid | [1] Pomalidomide Pomalidomide | [1] D08976
D08976
| [2] IL6 IL6, TNF 💬 | [80] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 28 28, 51 |
256 | Imnovid 1 mg hard capsules | [1] Pomalidomide Pomalidomide | [1] D08976
D08976
| [2] IL6 IL6, TNF 💬 | [80] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 51 51 |
257 | INCB039110 | - | - | - | - | [2] 51 51, 97 |
258 | Indocyanine green | [1] Indocyanine green Indocyanine green | [1] D01342
D01342
| - | - | [8] 22 22, 46, 51, 96, 235, 278, 291, 296 |
259 | Indole | [1] Indole Indole | - | - | - | [1] 51 51 |
260 | INEBILIZUMAB | [1] Inebilizumab Inebilizumab | [1] D11757
D11757
| [1] CD19 CD19 💬 | [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [4] 11 11, 13, 51, 300 |
261 | Influenza vaccine | - | - | - | - | [5] 11 11, 13, 46, 51, 84 |
262 | INJECTION OF ALLOGENEIC MESENCHYMAL STEM CELLS | - | - | - | - | [1] 51 51 |
263 | Injection of autologous stromal vascular fraction | - | - | - | - | [1] 51 51 |
264 | INTERLEUKIN 2 | - | - | - | - | [9] 46 46, 49, 51, 56, 63, 95, 96, 97, 271 |
265 | Intravenous Immunoglobulin | - | - | - | - | [8] 13 13, 14, 35, 38, 39, 49, 51, 309 |
266 | Iontophoresis of treprostinil | [1] Treprostinil Treprostinil | [1] D06213
D06213
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 51 51 |
267 | IS (B cell depletion therapy) | - | - | - | - | [5] 13 13, 35, 46, 49, 51 |
268 | IS (MMF or MPA) | - | - | - | - | [5] 13 13, 35, 46, 49, 51 |
269 | IS (MTX) | - | - | - | - | [5] 13 13, 35, 46, 49, 51 |
270 | Itacitinib | [1] Itacitinib Itacitinib | [1] D10944
D10944
| [1] JAK1 JAK1 💬 | [27] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [5] 46 46, 51, 60, 97, 228 |
271 | IV Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] D00287
D00287
,
D07760
| - | - | [1] 51 51 |
272 | IVA337 | - | - | - | - | [1] 51 51 |
273 | IVIG | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [8] 11 11, 13, 14, 17, 35, 50, 51, 65 |
274 | Ixazomib | [1] Ixazomib Ixazomib | [1] D10130
D10130
| [1] PSMB5 PSMB5 💬 | [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [4] 13 13, 16, 28, 51 |
275 | JBT-101 | - | - | - | - | [4] 49 49, 50, 51, 299 |
276 | KHK4827 | - | - | - | - | [2] 37 37, 51 |
277 | Lactobacillus | [1] Lactobacillus delbrueckii bulgaricus Lactobacillus delbrueckii bulgaricus | - | - | - | [5] 6 6, 46, 51, 97, 299 |
278 | LANIFIBRANOR | [1] Lanifibranor Lanifibranor | - | - | - | [1] 51 51 |
279 | Lenabasum | - | - | - | - | [3] 50 50, 51, 299 |
280 | Lenabasum 20 mg | - | - | - | - | [3] 50 50, 51, 299 |
281 | Lenabasum 20 mg Powder in Capsule | - | - | - | - | [1] 51 51 |
282 | Lenabasum 5 mg | - | - | - | - | [3] 50 50, 51, 299 |
283 | Lenabasum 5 mg Powder in Capsule | - | - | - | - | [1] 51 51 |
284 | Lenabasum 5mg Powder in Capsule | - | - | - | - | [1] 51 51 |
285 | Leukapheresis | - | - | - | - | [5] 49 49, 51, 96, 284, 285 |
286 | Leukopheresis | - | - | - | - | [1] 51 51 |
287 | Leuprolide | [1] Leuprolide Leuprolide | [1] D00989
D00989
| [1] GNRHR GNRHR 💬 | [2] GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | [5] 1 1, 2, 3, 51, 76 |
288 | Lidocaine | [1] Lidocaine Lidocaine | [3] D00358
D00358
,
D02086
,
D08127
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [12] 6 6, 13, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256 |
289 | Lidocaine 2% without vessel constrictor | [1] Lidocaine Lidocaine | [3] D00358
D00358
,
D02086
,
D08127
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 51 51 |
290 | Lipitor | [1] Atorvastatin Atorvastatin | [3] D00258
D00258
,
D00887
,
D07474
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [3] 51 51, 96, 299 |
291 | Liposomal bupivacaine | [1] Bupivacaine Bupivacaine | [2] D01450
D01450
,
D07552
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [3] 51 51, 70, 96 |
292 | MABp1 (Bermekimab) | [1] Bermekimab Bermekimab | [1] D11253
D11253
| [1] IL1A IL1A 💬 | [21] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Alzheimer disease, Cellular senescence, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Inflammatory bowel disease, Influenza A, Leishmaniasis, MAPK signaling pathway, Measles, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 51 51 |
293 | MabThera | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [22] 11 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 |
294 | Macitentan | [1] Macitentan Macitentan | [1] D10135
D10135
| [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [5] 51 51, 85, 86, 88, 210 |
295 | Macitentan 10 mg | [1] Macitentan Macitentan | [1] D10135
D10135
| [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 51 51, 86, 88 |
296 | Macitentan 10mg | [1] Macitentan Macitentan | [1] D10135
D10135
| [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 51 51, 88 |
297 | Macitentan 3 mg | [1] Macitentan Macitentan | [1] D10135
D10135
| [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
298 | Macitentan 3mg | [1] Macitentan Macitentan | [1] D10135
D10135
| [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
299 | Manual toothbrush | - | - | - | - | [1] 51 51 |
300 | Manual toothbrush and water flosser (Philips Sonicare AirFloss) | [1] Water Water | [1] D00001
D00001
| - | - | [1] 51 51 |
301 | Measurment with Aspirational Medical Device | - | - | - | - | [1] 51 51 |
302 | Measurment with Cutometer MPA 580 | - | - | - | - | [1] 51 51 |
303 | MEDI-546 | - | - | - | - | [2] 49 49, 51 |
304 | MEDI-551 | - | - | - | - | [2] 13 13, 51 |
305 | Medrone | - | - | - | - | [4] 46 46, 51, 83, 162 |
306 | Mesenchymal stem cells | - | - | - | - | [11] 2 2, 6, 13, 20, 49, 51, 60, 96, 222, 274, 299 |
307 | Mesenchymal Stem Cells from Wharton ´s jellyintravenous infusion of Mesenchymal Stem Cells from Wharton ´s jelly | - | - | - | - | [1] 51 51 |
308 | Mesenchymal Stromal Cells | [1] Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | [10] 2 2, 36, 49, 51, 60, 96, 97, 107, 274, 284 |
309 | Mesna | [1] Coenzyme M Coenzyme M | - | - | - | [11] 11 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 |
310 | Methotrexate | [1] Methotrexate Methotrexate | [2] D00142
D00142
,
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [38] 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 |
311 | Methoxsalen | [1] Methoxsalen Methoxsalen | [1] D00139
D00139
| - | - | [4] 36 36, 46, 51, 96 |
312 | Methylprednisolon | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [4] 13 13, 14, 51, 66 |
313 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
314 | METHYLPREDNISOLONE ACETATE | [2] Acetate Acetate, Methylprednisolone | [6] D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 46 46, 51 |
315 | METHYLPREDNISOLONE SODIUM SUCCINATE | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [6] 13 13, 46, 49, 50, 51, 211 |
316 | METOCLOPRAMIDE | [1] Metoclopramide Metoclopramide | [3] D00726
D00726
,
D02213
,
D05008
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 51 51 |
317 | METOCLOPRAMIDE ACCORD - 10 MG COMPRESSE 28 COMPRESSE IN BLISTER PVC/PVDC/AL | [1] Metoclopramide Metoclopramide | [3] D00726
D00726
,
D02213
,
D05008
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 51 51 |
318 | METRONIDAZOLE | [1] Metronidazole Metronidazole | [3] D00409
D00409
,
D05016
,
D05017
| - | - | [8] 46 46, 51, 63, 94, 95, 96, 97, 291 |
319 | Mg | - | - | - | - | [4] 6 6, 13, 51, 111 |
320 | MHSCT | - | - | - | - | [1] 51 51 |
321 | Microgynon | - | - | - | - | [2] 13 13, 51 |
322 | Mizoribine | [1] Mizoribine Mizoribine | [1] D01392
D01392
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [8] 46 46, 49, 51, 53, 66, 94, 222, 224 |
323 | MMF | - | - | - | - | [15] 13 13, 35, 40, 46, 49, 50, 51, 60, 65, 66, 162, 222, 224, 226, 299 |
324 | Moderna mRNA-1273 | - | - | - | - | [5] 13 13, 35, 46, 49, 51 |
325 | MPA | - | - | - | - | [6] 13 13, 35, 46, 49, 51, 60 |
326 | MQX-503 | - | - | - | - | [1] 51 51 |
327 | MSC | - | - | - | - | [6] 6 6, 51, 60, 96, 97, 271 |
328 | MT-7117 | - | - | - | - | [2] 51 51, 254 |
329 | MTX | - | - | - | - | [14] 13 13, 35, 40, 46, 49, 50, 51, 60, 84, 96, 97, 107, 162, 271 |
330 | Mycophenolate | [1] Mycophenolic acid Mycophenolic acid | [1] D05096
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [36] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
331 | Mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [4] D00752
D00752
,
D05094
,
D05095
,
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [34] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
332 | Mycophenolate mofetil (MMF) | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [4] D00752
D00752
,
D05094
,
D05095
,
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [7] 13 13, 49, 51, 60, 65, 66, 222 |
333 | Mycophenolate Mofetil 500mg | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [4] D00752
D00752
,
D05094
,
D05095
,
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [3] 49 49, 51, 61 |
334 | Mycophenolic acid | [1] Mycophenolic acid Mycophenolic acid | [1] D05096
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [8] 11 11, 43, 49, 51, 60, 66, 96, 222 |
335 | N-acetylcysteine (NAC) | [1] Acetylcysteine Acetylcysteine | [1] D00221
D00221
| - | - | [3] 34 34, 51, 299 |
336 | NAC | - | - | - | - | [5] 34 34, 51, 85, 90, 299 |
337 | Nd | - | - | - | - | [6] 2 2, 6, 13, 46, 51, 97 |
338 | Nemolizumab | [1] Nemolizumab Nemolizumab | [1] D11080
D11080
| [1] IL31RA IL31RA 💬 | [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [1] 51 51 |
339 | Neovasculgen | - | - | - | - | [1] 51 51 |
340 | NEUPOGEN | - | - | - | - | [4] 13 13, 28, 51, 285 |
341 | Nilotinib | [1] Nilotinib Nilotinib | [1] D08953
D08953
| [4] ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | [33] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [5] 6 6, 8, 34, 51, 86 |
342 | Nilotinib (Tasigna) | [1] Nilotinib Nilotinib | [1] D08953
D08953
| [4] ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | [33] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 51 51 |
343 | NINTEDANIB | [1] Nintedanib Nintedanib | [1] D10481
D10481
| [8] FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 | [34] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [5] 51 51, 85, 89, 227, 228 |
344 | Nitroglycerin | [1] Nitroglycerin Nitroglycerin | [1] D00515
D00515
| - | - | [1] 51 51 |
345 | Nitroglycerin Ointment 2% | [1] Nitroglycerin Nitroglycerin | [1] D00515
D00515
| - | - | [1] 51 51 |
346 | Nitroglycerine | [1] Nitroglycerin Nitroglycerin | [1] D00515
D00515
| - | - | [2] 46 46, 51 |
347 | Nitroglycerine gel | [1] Nitroglycerin Nitroglycerin | [1] D00515
D00515
| - | - | [1] 51 51 |
348 | Nitroprusside | [1] Nitroprusside Nitroprusside | [1] D00614
D00614
| - | - | [1] 51 51 |
349 | Nivolumab | [1] Nivolumab Nivolumab | [1] D10316
D10316
| [1] PDCD1 PDCD1 💬 | [3] Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | [12] 13 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 |
350 | Non applicabile | - | - | - | - | [4] 13 13, 49, 51, 256 |
351 | NON PROPIETRY, THEREFORE N/A | - | - | - | - | [1] 51 51 |
352 | None | - | - | - | - | [16] 6 6, 46, 51, 65, 78, 84, 85, 96, 97, 140, 160, 161, 171, 231, 271, 299 |
353 | None yet | [1] Interleukin-1 alpha, human recombinant Interleukin-1 alpha, human recombinant | - | - | - | [1] 51 51 |
354 | Nonmyeloablative allogeneic hematopoietic stem cell transplantation | - | - | - | - | [6] 28 28, 51, 60, 62, 65, 285 |
355 | Null | - | - | - | - | [16] 6 6, 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 |
356 | Ofev | [1] Nintedanib Nintedanib | [1] D10481
D10481
| [8] FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 | [34] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [5] 51 51, 85, 89, 227, 228 |
357 | Omeprazole | [1] Omeprazole Omeprazole | [4] D00455
D00455
,
D01207
,
D05259
,
D05261
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [16] 6 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
358 | Omeprazole 20mg | [1] Omeprazole Omeprazole | [4] D00455
D00455
,
D01207
,
D05259
,
D05261
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 51 51 |
359 | Onabotulinumtoxin A | - | - | - | - | [2] 51 51, 226 |
360 | Ophthalmic Emulsion | - | - | - | - | [2] 51 51, 53 |
361 | Opsumit 10 Mg Tablet | - | - | - | - | [1] 51 51 |
362 | Oral bovine type I collagen | [1] Bovine type I collagen Bovine type I collagen | - | - | - | [1] 51 51 |
363 | Oral Ifetroban | [1] Ifetroban Ifetroban | [1] D04500
D04500
| [1] TBXA2R TBXA2R 💬 | [3] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 💬 | [2] 51 51, 86 |
364 | Oral treprostinil | [1] Treprostinil Treprostinil | [1] D06213
D06213
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [2] 51 51, 86 |
365 | Order of two elements of surgical procedure | - | - | - | - | [1] 51 51 |
366 | ORENCIA | [1] Abatacept Abatacept | [1] D03203
D03203
| [2] CD80 CD80, CD86 💬 | [12] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | [14] 44 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 160, 222, 271 |
367 | ORM-12471 | - | - | - | - | [1] 51 51 |
368 | ORM-12471 30mg | - | - | - | - | [1] 51 51 |
369 | ORM-12741 | [1] ORM-12741 ORM-12741 | - | - | - | [1] 51 51 |
370 | Other vasodilator | - | - | - | - | [1] 51 51 |
371 | Other: Biopsy | - | - | - | - | [1] 51 51 |
372 | Other: Blood draws | - | - | - | - | [3] 49 49, 51, 85 |
373 | Other: Bronchoalveolar samples | - | - | - | - | [1] 51 51 |
374 | Other: Clinical data collection | - | - | - | - | [3] 49 49, 51, 85 |
375 | Other: Dietary recommendations | - | - | - | - | [1] 51 51 |
376 | Other: Extracorporeal Photopheresis (ECP) with Methoxsalen | [1] Methoxsalen Methoxsalen | [1] D00139
D00139
| - | - | [1] 51 51 |
377 | Other: flow cytometry | - | - | - | - | [3] 28 28, 51, 60 |
378 | Other: Genetic data/DNA/RNA | - | - | - | - | [3] 49 49, 51, 85 |
379 | Other: Laboratory Biomarker Analysis | - | - | - | - | [21] 11 11, 13, 14, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 |
380 | Other: Other biological samples to biobank (skin, lung and muscle biopsies | - | - | - | - | [3] 49 49, 51, 85 |
381 | Other: ozone therapy | [1] Ozone Ozone | - | - | - | [1] 51 51 |
382 | Other: Physalis angulata ethanol extract | [1] Ethanol Ethanol | [4] D00068
D00068
,
D02798
,
D04855
,
D06542
| - | - | [1] 51 51 |
383 | Other: Quality-of-Life Assessment | - | - | - | - | [9] 34 34, 36, 51, 62, 65, 96, 283, 286, 298 |
384 | Other: Questionnaire Administration | - | - | - | - | [4] 16 16, 34, 51, 298 |
385 | Other: Rosemary essential oil | [1] Rosemary Rosemary | - | - | - | [1] 51 51 |
386 | Other: sodium chloride | [2] Chloride ion Chloride ion, Sodium chloride | [1] D02056
D02056
| - | - | [1] 51 51 |
387 | Other: Standard treatment according to the Clinical protocols | - | - | - | - | [3] 49 49, 51, 235 |
388 | Ozone | [1] Ozone Ozone | - | - | - | [3] 49 49, 51, 226 |
389 | P144 | - | - | - | - | [1] 51 51 |
390 | P144 cream | - | - | - | - | [1] 51 51 |
391 | P144 Cytokine Inhibitor | - | - | - | - | [1] 51 51 |
392 | P144 Cytokines Inhibitors | - | - | - | - | [1] 51 51 |
393 | P144 DIGNA CREAM | - | - | - | - | [1] 51 51 |
394 | P144. Cytokines Inhibitors | - | - | - | - | [1] 51 51 |
395 | Paquinimod | [1] Paquinimod Paquinimod | - | - | - | [2] 49 49, 51 |
396 | Part B Open-Label Extension | - | - | - | - | [1] 51 51 |
397 | Patients will be randomized to receive EHP-101 | - | - | - | - | [1] 51 51 |
398 | Penicillamine | [1] Penicillamine Penicillamine | [1] D00496
D00496
| - | - | [2] 51 51, 171 |
399 | Peripheral Blood Stem Cell Transplantation | - | - | - | - | [12] 11 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285, 286 |
400 | Peripheral Blood Stem Cells | - | - | - | - | [2] 51 51, 65 |
401 | PFD | - | - | - | - | [3] 51 51, 117, 298 |
402 | Phosphate | [1] Phosphate ion Phosphate ion | - | - | - | [33] 2 2, 3, 6, 11, 12, 13, 15, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299 |
403 | Phosphodiesterase Inhibitors | - | - | - | - | [1] 51 51 |
404 | Physiological saline | - | - | - | - | [1] 51 51 |
405 | Pirfenidone | [1] Pirfenidone Pirfenidone | [1] D01583
D01583
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 | [84] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [11] 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
406 | Pirfenidone (PFD) | [1] Pirfenidone Pirfenidone | [1] D01583
D01583
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 | [84] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 51 51 |
407 | Placebo | - | - | - | - | [27] 3 3, 5, 6, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 |
408 | PLACENTEX ® Polydeoxyribonucleotide | - | - | - | - | [1] 51 51 |
409 | PLACENTEX ¿ Polydeoxyribonucleotide 5.625 mg/3 ml | - | - | - | - | [1] 51 51 |
410 | PLACENTEX ¿5.625 mg/3 ml soluzione iniettabile¿ | - | - | - | - | [1] 51 51 |
411 | Platelet Gel | - | - | - | - | [1] 51 51 |
412 | PLERIXAFOR | [1] Plerixafor Plerixafor | [1] D08971
D08971
| [1] CXCR4 CXCR4 💬 | [12] Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor 💬 | [5] 20 20, 51, 65, 285, 299 |
413 | PLETAL | [1] Cilostazol Cilostazol | [1] D01896
D01896
| [3] PDE3A PDE3A, PDE3B, TBXA2R 💬 | [14] Apelin signaling pathway Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
414 | POLYDEOXYRIBONUCLEOTIDES | - | - | - | - | [2] 51 51, 70 |
415 | Pomalidomida | [1] Pomalidomide Pomalidomide | [1] D08976
D08976
| [2] IL6 IL6, TNF 💬 | [80] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 51 51 |
416 | Pomalidomide | [1] Pomalidomide Pomalidomide | [1] D08976
D08976
| [2] IL6 IL6, TNF 💬 | [80] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [6] 28 28, 34, 51, 85, 227, 331 |
417 | Pomalidomide (CC-4047) | [1] Pomalidomide Pomalidomide | [1] D08976
D08976
| [2] IL6 IL6, TNF 💬 | [80] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 51 51 |
418 | PR1 | - | - | - | - | [1] 51 51 |
419 | PRA023 IV | - | - | - | - | [3] 51 51, 96, 97 |
420 | Prednisolon | - | - | - | - | [7] 46 46, 50, 51, 66, 95, 96, 97 |
421 | Prednisolona | [1] Prednisolone Prednisolone | [8] D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 51 51 |
422 | PREDNISOLONE | [1] Prednisolone Prednisolone | [8] D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [43] 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
423 | Prednisolone 5 mg | [1] Prednisolone Prednisolone | [8] D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 46 46, 51 |
424 | Prednisolone 5mg Gastro-resistant Tablets | [1] Prednisolone Prednisolone | [8] D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 51 51 |
425 | Prednisolone and taper | [1] Prednisolone Prednisolone | [8] D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 51 51 |
426 | Prednisoloni | - | - | - | - | [1] 51 51 |
427 | Prednisolonum | [1] Prednisolone Prednisolone | [8] D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 51 51 |
428 | Prednisone | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 2 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
429 | Prednizolon | - | - | - | - | [1] 51 51 |
430 | Prednizolonas | - | - | - | - | [1] 51 51 |
431 | PRIVIGEN | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [4] 11 11, 14, 51, 65 |
432 | PRIVIGEN - 100 MG/ML - SOLUZIONE PER INFUSIONE USO ENDOVENOSO FLACONCINO(VETRO) 1 FLACONCINO DA 100 ML | - | - | - | - | [1] 51 51 |
433 | Propylene glycol | [1] Propylene glycol Propylene glycol | [1] D00078
D00078
| - | - | [2] 28 28, 51 |
434 | Prostanoids | - | - | - | - | [1] 51 51 |
435 | PRUCALOPRIDE | [1] Prucalopride Prucalopride | [1] D09205
D09205
| [1] HTR4 HTR4 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬 | [3] 13 13, 51, 96 |
436 | PRUCALOPRIDE SUCCINATE | [1] Prucalopride Prucalopride | [1] D09205
D09205
| [1] HTR4 HTR4 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬 | [1] 51 51 |
437 | Pyrophosphate | - | - | - | - | [1] 51 51 |
438 | QAX576 | - | - | - | - | [4] 51 51, 85, 96, 98 |
439 | Quality-of-life assessment | - | - | - | - | [3] 28 28, 34, 51 |
440 | Rabbit | [1] Rabbit Rabbit | - | - | - | [8] 11 11, 13, 49, 51, 60, 65, 96, 285 |
441 | Rabeprazole | [1] Rabeprazole Rabeprazole | [2] D00724
D00724
,
D08463
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [2] 2 2, 51 |
442 | Radiation: Cone Beam Computed Tomography (CBCT) | [1] Tricyclazole Tricyclazole | - | - | - | [1] 51 51 |
443 | Radiation: Intensity-Modulated Radiation Therapy | - | - | - | - | [1] 51 51 |
444 | Radiation: Total Body Irradiation | - | - | - | - | [7] 36 36, 49, 51, 60, 65, 283, 284 |
445 | Radiation: total-body irradiation | - | - | - | - | [9] 28 28, 51, 60, 62, 65, 96, 283, 284, 285 |
446 | Rapamycin | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [19] 2 2, 15, 34, 35, 46, 49, 51, 60, 61, 67, 86, 89, 96, 157, 158, 193, 256, 278, 279 |
447 | RATG | [1] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | - | - | - | [4] 13 13, 51, 60, 285 |
448 | RbATG | - | - | - | - | [2] 51 51, 96 |
449 | Recombinant humanized anti-human monoclonal antibody directed against the IL-6R | - | - | - | - | [3] 46 46, 51, 107 |
450 | Reduced intensity allogeneic hematopoietic stem cell transplantation | - | - | - | - | [1] 51 51 |
451 | Reduced Intensity Allogeneic Transplant | - | - | - | - | [2] 49 49, 51 |
452 | Relaxin | - | - | - | - | [1] 51 51 |
453 | Resolor | [1] Prucalopride Prucalopride | [1] D09205
D09205
| [1] HTR4 HTR4 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬 | [1] 51 51 |
454 | RESOLOR*28CPR RIV 2MG | [1] Prucalopride Prucalopride | [1] D09205
D09205
| [1] HTR4 HTR4 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬 | [1] 51 51 |
455 | Resunab, ajulemic acid, anabasum | [1] Ajulemic acid Ajulemic acid | [1] D11312
D11312
| [1] CNR2 CNR2 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 50 50, 51, 299 |
456 | Rilonacept | [1] Rilonacept Rilonacept | [1] D06635
D06635
| [2] IL1A IL1A, IL1B 💬 | [45] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [4] 51 51, 106, 107, 266 |
457 | Ringer lactate | - | - | - | - | [1] 51 51 |
458 | Riocigu | - | - | - | - | [1] 51 51 |
459 | RIOCIGUAT | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [6] 51 51, 84, 86, 88, 225, 299 |
460 | Riociguat (Adempas, BAY63-2521) | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [4] 51 51, 86, 88, 299 |
461 | Riociguat coated tablet 0.5 mg | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
462 | Riociguat coated tablet 1.0 mg | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
463 | Riociguat coated tablet 1.5 mg | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
464 | Riociguat coated tablet 2.0 mg | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
465 | Riociguat coated tablet 2.5 m | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
466 | Riociguat coated tablet 2.5 mg | [1] Riociguat Riociguat | [1] D09572
D09572
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬 | [11] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
467 | Rituximab | [1] Rituximab Rituximab | [1] D02994
D02994
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [49] 6 6, 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
468 | Ro 47-0203 | - | - | - | - | [4] 51 51, 85, 86, 88 |
469 | Ro 487-7533/F10-04 | - | - | - | - | [4] 41 41, 46, 51, 107 |
470 | Ro47-0203 / ACT-050088 | - | - | - | - | [2] 51 51, 86 |
471 | RO487-7533/F10-04 | - | - | - | - | [2] 46 46, 51 |
472 | RoActemra | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [11] 40 40, 41, 44, 46, 50, 51, 86, 107, 266, 271, 331 |
473 | ROACTEMRA - 162 MG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA 0,9ML (VETRO) - 4 SIRINGHE PRERIEMPITE | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 51 51 |
474 | RoActemra 162 mg | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [2] 46 46, 51 |
475 | Rosemary | [1] Rosemary Rosemary | - | - | - | [1] 51 51 |
476 | Rosuvastatin | [1] Rosuvastatin Rosuvastatin | [2] D01915
D01915
,
D08492
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [11] 6 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 |
477 | Saccharomyces | [1] Saccharomyces cerevisiae Saccharomyces cerevisiae | - | - | - | [1] 51 51 |
478 | Saccharomyces Boulardii Oral Tablet | [1] Saccharomyces cerevisiae Saccharomyces cerevisiae | - | - | - | [1] 51 51 |
479 | SAR100842 | - | - | - | - | [2] 51 51, 85 |
480 | SAR156597 | - | - | - | - | [2] 51 51, 85 |
481 | SAR231893 | - | - | - | - | [2] 51 51, 160 |
482 | Selexipag | [1] Selexipag Selexipag | [1] D09994
D09994
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [6] 47 47, 51, 70, 84, 86, 88 |
483 | Self bone marrow transplant | - | - | - | - | [1] 51 51 |
484 | Serial night time position splint | - | - | - | - | [1] 51 51 |
485 | Sildenafil | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [17] 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 |
486 | Sildenafil 20mg | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 |
487 | Sildenafil 20mg and Bosentan 62.5mg | [2] Bosentan Bosentan, Sildenafil | [4] D01227
D01227
,
D02229
,
D07538
,
D08514
| [3] EDNRA EDNRA, EDNRB, PDE5A 💬 | [11] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 |
488 | Sildenafil citrate | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [4] 51 51, 85, 86, 225 |
489 | Sildenafil therapy | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
490 | Simvastatin | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [21] 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 |
491 | Sinvacor | - | - | - | - | [1] 51 51 |
492 | SINVACOR*28CPR RIV 20MG | - | - | - | - | [1] 51 51 |
493 | Sirolimus | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [36] 6 6, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 |
494 | Sodium chloride | [2] Chloride ion Chloride ion, Sodium chloride | [1] D02056
D02056
| - | - | [21] 6 6, 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 67, 78, 96, 168, 193, 227, 228, 271, 288, 299 |
495 | Sodium fluoride | [1] Sodium fluoride Sodium fluoride | [1] D00943
D00943
| - | - | [1] 51 51 |
496 | Sodium fluoride 18F | [1] Sodium fluoride Sodium fluoride | [1] D00943
D00943
| - | - | [1] 51 51 |
497 | SODIUM NITROPRUSSIDE | [1] Nitroprusside Nitroprusside | [1] D00614
D00614
| - | - | [1] 51 51 |
498 | Sodium Thiosulfate | - | - | - | - | [2] 50 50, 51 |
499 | Sodium Thiosulfate 10% | - | - | - | - | [2] 50 50, 51 |
500 | SODIUM THIOSULFATE PENTAHYDRATE | - | - | - | - | [2] 50 50, 51 |
501 | Solid state catheter | - | - | - | - | [1] 51 51 |
502 | Solu-Medrol | [1] Methylprednisolone hemisuccinate Methylprednisolone hemisuccinate | [1] D05000
D05000
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [7] 13 13, 49, 50, 51, 53, 97, 211 |
503 | Solu-Medrone | - | - | - | - | [3] 51 51, 83, 162 |
504 | Soluble Ve cadherin | - | - | - | - | [1] 51 51 |
505 | Sonic toothbrush | - | - | - | - | [1] 51 51 |
506 | Sonic toothbrush (Philips Sonicare) and water flosser (Philips Sonicare AirFloss) | [1] Water Water | [1] D00001
D00001
| - | - | [1] 51 51 |
507 | Standard of Care | - | - | - | - | [10] 6 6, 13, 46, 49, 51, 63, 64, 79, 171, 271 |
508 | Stem Cell Transplantation | - | - | - | - | [13] 13 13, 19, 20, 46, 51, 60, 62, 65, 90, 125, 164, 234, 326 |
509 | Sterile saline solution | - | - | - | - | [1] 51 51 |
510 | Steroids | - | - | - | - | [7] 46 46, 50, 51, 63, 66, 96, 97 |
511 | STI571 | - | - | - | - | [2] 51 51, 86 |
512 | Stromal Vascular fraction | - | - | - | - | [1] 51 51 |
513 | STS | - | - | - | - | [2] 50 50, 51 |
514 | Study of the gene expression profile | - | - | - | - | [1] 51 51 |
515 | Tacrolimus | [1] Tacrolimus Tacrolimus | [2] D00107
D00107
,
D08556
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [34] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
516 | Tadalafil | [1] Tadalafil Tadalafil | [1] D02008
D02008
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [7] 6 6, 51, 75, 84, 86, 113, 210 |
517 | Tadalafil and ambrisentan upfront combination therapy | [2] Ambrisentan Ambrisentan, Tadalafil | [2] D02008
D02008
,
D07077
| [2] EDNRA EDNRA, PDE5A 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 |
518 | Temanogrel | - | - | - | - | [1] 51 51 |
519 | TEPEZZA | [1] Teprotumumab Teprotumumab | [1] D09680
D09680
| [1] IGF1R IGF1R 💬 | [29] AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, HIF-1 signaling pathway, Hepatocellular carcinoma, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | [1] 51 51 |
520 | Terguride | [1] Terguride Terguride | [1] D01348
D01348
| [2] DRD2 DRD2, PRL 💬 | [12] Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [2] 51 51, 86 |
521 | TERGURIDE HYDROGENMALEATE | [1] Terguride Terguride | [1] D01348
D01348
| [2] DRD2 DRD2, PRL 💬 | [12] Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 51 51 |
522 | Thalidomide | [1] Thalidomide Thalidomide | [1] D00754
D00754
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [20] 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 |
523 | The ozone generator device (Human Pro medic, German) | [1] Ozone Ozone | - | - | - | [1] 51 51 |
524 | Thiotepa | [1] Thiotepa Thiotepa | [1] D00583
D00583
| - | - | [12] 13 13, 19, 20, 28, 51, 60, 65, 85, 96, 164, 284, 285 |
525 | Thymoglobulin | [1] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | - | - | - | [7] 36 36, 51, 60, 65, 96, 285, 326 |
526 | THYMOGLOBULINE | [1] Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | - | - | - | [5] 13 13, 36, 51, 60, 96 |
527 | Tocilizumab | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [21] 2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 |
528 | Tocilizumab [RoActemra/Actemra] | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [4] 46 46, 51, 107, 331 |
529 | Tocilizumab SC 162 mg/0.9 ml prefilled syringe with safety device (PFS) | [1] Tocilizumab Tocilizumab | [1] D02596
D02596
| [1] IL6R IL6R 💬 | [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 51 51 |
530 | Tofacitinib | [1] Tofacitinib Tofacitinib | [1] D09970
D09970
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬 | [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [15] 11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 256, 271 |
531 | Topical AmphiMatrix | - | - | - | - | [1] 51 51 |
532 | Topical AmphiMatrix with nitroglycerin (MQX-503) | [1] Nitroglycerin Nitroglycerin | [1] D00515
D00515
| - | - | [1] 51 51 |
533 | Topical calcipotriene 0.005% ointment | [1] Calcipotriol Calcipotriol | [1] D01125
D01125
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 51 51 |
534 | Topical organogel with nitroglycerin | [1] Nitroglycerin Nitroglycerin | [1] D00515
D00515
| - | - | [1] 51 51 |
535 | Total body Irradiation | - | - | - | - | [6] 19 19, 20, 51, 60, 65, 285 |
536 | Total-Body Irradiation | - | - | - | - | [1] 51 51 |
537 | Tracleer | [1] Bosentan Bosentan | [2] D01227
D01227
,
D07538
| [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [8] 13 13, 51, 84, 85, 86, 88, 210, 211 |
538 | TRACLEER*125MG 56CPR RIV. | [1] Bosentan Bosentan | [2] D01227
D01227
,
D07538
| [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 |
539 | TRACLEER*56CPR RIV 125MG | [1] Bosentan Bosentan | [2] D01227
D01227
,
D07538
| [2] EDNRA EDNRA, EDNRB 💬 | [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 51 51, 86, 88 |
540 | Transdihydrolisuride | - | - | - | - | [2] 51 51, 86 |
541 | Treprostinil | [1] Treprostinil Treprostinil | [1] D06213
D06213
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [6] 51 51, 84, 85, 86, 88, 210 |
542 | Treprostinil diethanolamine | [1] Treprostinil Treprostinil | [1] D06213
D06213
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [2] 51 51, 86 |
543 | TREPROSTINIL SODIUM | [1] Treprostinil Treprostinil | [1] D06213
D06213
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [3] 51 51, 86, 88 |
544 | Trimebutine | [1] Trimebutine Trimebutine | [1] D08639
D08639
| [2] OPRK1 OPRK1, OPRM1 💬 | [3] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | [1] 51 51 |
545 | Trometamol | [1] Tromethamine Tromethamine | [1] D00396
D00396
| - | - | [1] 51 51 |
546 | UCMSC | - | - | - | - | [2] 51 51, 94 |
547 | Ultraviolet A1 phototherapy (UVA1) | - | - | - | - | [1] 51 51 |
548 | Urine sample | - | - | - | - | [3] 49 49, 51, 61 |
549 | UT-15 SR | - | - | - | - | [1] 51 51 |
550 | UT-15C SR | - | - | - | - | [2] 51 51, 86 |
551 | UT-15C-SR | - | - | - | - | [2] 51 51, 86 |
552 | Vaseline | - | - | - | - | [1] 51 51 |
553 | Veledimex | [1] Veledimex Veledimex | [1] D10678
D10678
| - | - | [1] 51 51 |
554 | Vessel | - | - | - | - | [4] 13 13, 51, 271, 288 |
555 | VIB7734 | - | - | - | - | [4] 49 49, 50, 51, 53 |
556 | VIP | - | - | - | - | [3] 49 49, 51, 86 |
557 | Vitamin D3 | [1] Cholecalciferol Cholecalciferol | [1] D00188
D00188
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [12] 6 6, 13, 20, 46, 49, 51, 53, 60, 65, 96, 97, 299 |
558 | Vivomixx probiotics | - | - | - | - | [1] 51 51 |
559 | Volibris | [1] Ambrisentan Ambrisentan | [1] D07077
D07077
| [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [4] 51 51, 85, 86, 88 |
560 | Water | [1] Water Water | [1] D00001
D00001
| - | - | [23] 2 2, 5, 6, 13, 17, 19, 22, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 |
561 | Yellow fever vaccine | [1] Yellow fever vaccine Yellow fever vaccine | [1] D06347
D06347
| - | - | [8] 40 40, 44, 46, 50, 51, 52, 53, 107 |
562 | Yellow Fever vaccine (17D) | [1] Yellow fever vaccine Yellow fever vaccine | [1] D06347
D06347
| - | - | [8] 40 40, 44, 46, 50, 51, 52, 53, 107 |
563 | ZD4054 | - | - | - | - | [1] 51 51 |
564 | Zibotentan | [1] Zibotentan Zibotentan | [1] D07741
D07741
| [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
565 | Ziritaxestat | [1] Ziritaxestat Ziritaxestat | [1] D11844
D11844
| [1] ENPP2 ENPP2 💬 | [2] Ether lipid metabolism Ether lipid metabolism, Metabolic pathways 💬 | [2] 51 51, 85 |